Filing Details

Accession Number:
0001104659-25-062678
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-25 20:24:22
Reporting Period:
2025-06-23
Filing Date:
2025-06-25
Accepted Time:
2025-06-25 20:24:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1533615 Global Medical Reit Inc. GMRE Real Estate Investment Trusts (6798) 464757266
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1681625 Jr Okey Mark Decker 7373 Wisconsin Avenue, Suite 800
Bethesda MD 20814
Ceo And President Yes Yes No No
Transaction Summary
Purchased: 160,000 shares Avg. Price: $6.52 Total Value: $1,042,527.97
Number of Shares After Transactions: 160,000 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-06-24 100,000 $6.53 100,000 No 4 P Direct
Common Stock Acquisiton 2025-06-24 2,668 $6.37 102,668 No 4 P Direct
Common Stock Acquisiton 2025-06-25 30,757 $6.47 133,425 No 4 P Direct
Common Stock Acquisiton 2025-06-25 8,072 $6.56 141,497 No 4 P Direct
Common Stock Acquisiton 2025-06-25 18,503 $6.54 160,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock LTIP Unit (Right to Buy) Acquisiton 2025-06-23 158,730 $0.00 158,730 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
158,730 No 4 A Direct
Footnotes
  1. This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.31 to $6.60, inclusive. The amount reflected has been rounded to four decimal points. The reporting person undertakes to provide to Global Medical REIT Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) through (5) to this Form 4.
  2. This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.32 to $6.40, inclusive. The amount reflected has been rounded to four decimal points.
  3. This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.44 to $6.505, inclusive. The amount reflected has been rounded to four decimal points.
  4. This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.555 to $6.585, inclusive. The amount reflected has been rounded to four decimal points.
  5. This is the weighted average purchase price. Shares were purchased in multiple transactions at prices ranging from $6.4925 to $6.615, inclusive. The amount reflected has been rounded to four decimal points.
  6. Represents units of limited partnership interests ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer, that were granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan (as amended from time to time) in connection with the Reporting Person's appointment as President and Chief Executive Officer, effective June 23, 2025 (the "grant date"). All of the LTIP Units vest on the third anniversary of the grant date.
  7. As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.